Biogen (BIIB) option implied volatility into Clinical Trials on Alzheimer's Congress
Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 22, December weekly is at 55, December is at 56; compared to its 52-week range 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.
